Maynard Um
-
-
-
-
-
-
-
Humacyte presents research on dialysis access vessel self-repair at VASA meeting
-
-
-
-
-
-
-
Humacyte realigns ex-US rights to Symvess with Fresenius Medical Care
-
-
-
-
-
-
-
Humacyte secures $1.475 million Saudi Arabia purchase commitment
-
-
-
-
-
-
-
Humacyte plans to file for marketing approval of Symvess in Israel
-
-
-
-
-
-
-
Humacyte publishes CTEV coronary bypass data, plans human trials
-
-
-
-
-
-
-
Humacyte (HUMA) PT Lowered to $7 at BTIG
-
-
-
-
-
-
-
Humacyte, Inc. (HUMA) Tops Q4 EPS by 9c
-
434,651 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

